Status
Conditions
Treatments
About
The goal of this randomized controlled trial is to determine whether primary prophylaxis with transpapillary gallbladder drainage prevents acute cholecystitis after fully-covered self-expandable metal stents placement during endoscopic retrograde cholangiopancreatography for malignant distal biliary obstruction in patients at higher risk of post-endoscopic retrograde cholangiopancreatography acute cholecystitis.
The main question it aims to answer is:
Does prophylactic transpapillary gallbladder drainage reduce the rate of post-endoscopic retrograde cholangiopancreatography acute cholecystitis in high-risk patients? Researchers will compare patients who undergo transpapillary gallbladder drainage to patients without transpapillary gallbladder drainage to see if transpapillary gallbladder drainage reduces the rate of acute cholecystitis.
Participants will:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult patients
Signed informed consent
Patients requiring covered metal stent placement for managing MBO
High-risk of post-endoscopic cholangiopancreatography acute cholecystitis according to the following criteria:
tumor involvement of the cystic duct orifice confirmed on magnetic resonance imaging, computed tomography, endoscopic ultrasound, or at endoscopic cholangiopancreatography;
presence of at least 2 of the following:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Central trial contact
Stefano Francesco Crinò, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal